Nanoscale lucid ganoderma as well as preparation method and application thereof

Treating Ganoderma lucidum by nano spray drying solves the problem of pharmacological activity caused by high extraction rate, improves its anti-inflammatory, antioxidant and whitening effects, is suitable for cosmetic applications in cosmetics, and realizes the efficient utilization of Ganoderma lucidum extract.

CN119015181APending Publication Date: 2024-11-26GUANGDONG PHARMA UNIV
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411423580.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-12
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

In the existing Ganoderma lucidum extraction technology, the high extraction rate leads to the inclusion of a large number of substances without pharmacological activity in the extract, which reduces the concentration of active ingredients, makes it difficult to achieve anti-tumor activity pharmacological activity, and lacks cosmetic applications in cosmetics.

Method used

Nanospray drying is used to treat Ganoderma lucidum into nano-scale particles. Through vacuum microwave and nano-spray drying technology, process parameters are optimized to improve the particle size and bioavailability of Nanospray drying, and enhance its anti-inflammatory, antioxidant and whitening effects.

Benefits of technology

It improves the absorption rate of Ganoderma lucidum extract and drug loading efficiency, significantly enhances its anti-inflammatory, antioxidant and whitening effects, improves skin condition, and shows the effect of improving seborrheic hair loss in cosmetics.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015181A_ABST
    Figure CN119015181A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of lucid ganoderma traditional Chinese medicinal material treatment, and particularly relates to nanoscale lucid ganoderma as well as a preparation method and application thereof. The preparation method comprises the following steps: (1) soaking lucid ganoderma, performing vacuum microwave treatment, dissolving the lucid ganoderma in water, stirring, and filtering to obtain a nano spray drying preparation solution; (2) performing nano spray drying on the nano spray drying preparation solution to obtain nano-scale lucid ganoderma; wherein the parameters of the nano spray drying are as follows: the inlet temperature of a spray drying cylinder is 95-105 DEG C. According to the invention, the active ingredients of the ganoderma lucidum extract can be absorbed more greatly by adopting a nanotechnology, and the ganoderma lucidum extract has the properties of viscosity, hydrophilicity, permeability, solubility and the like which meet the requirements.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of ganoderma lucidum Chinese medicinal material processing, and specifically relates to a nano-level ganoderma lucidum and a preparation method and application thereof. Background Art

[0002] Ganoderma lucidum is the dried fruiting body of the Polyporaceae fungus Ganoderma lucidum. It is sweet and mild in nature, and can strengthen the body. It enters the heart, liver, lung, and kidney meridians, can calm the mind, strengthen the spleen and stomach, and replenish qi and blood. It is mainly used to treat insomnia, fatigue, palpitations, coronary heart disease, tumors, etc. Ganoderma lucidum contains a variety of chemical components, among which the active ingredients are mainly polysaccharides, trisaccharides, ribosomal, and sterols, and have certain anti-tumor, anti-inflammatory, liver protection, hypoglycemic, and anti-aging activities.

[0003] Ganoderma triterpenoids are important active ingredients of Ganoderma lucidum, including acidic triterpenoids and neutral triterpenoids, which have certain anti-tumor activity. Compared with Ganoderma lucidum polysaccharides, which act indirectly on tumor cells, Ganoderma triterpenoids have direct cytotoxic effects on tumor cells. Different types of Ganoderma lucidum triterpenoids have different anti-tumor activities. Experiments have shown that acidic triterpenoids have many effects such as anti-inflammatory and immune regulation, but the anti-tumor activity of neutral triterpenoids is significantly stronger than that of acidic triterpenoids.

[0004] In the extraction of Ganoderma lucidum, high-tech is generally used to pursue a high extraction rate of effective ingredients. However, it is not known that the high extraction rate of effective ingredients brings about a high yield of the extract, resulting in the presence of many substances without pharmacological activity in the extract. Because the triterpenes and polysaccharides in the fruiting bodies of Ganoderma lucidum have an upper limit, the high yield leads to the extraction of a large number of substances without pharmacological activity in the fruiting bodies of Ganoderma lucidum, reducing the concentration of effective ingredients in the extract. If the extract with high yield and low effective ingredient content is directly used for anti-tumor activity detection, it may not even reach the pharmacological activity of the extract prepared by conventional processes. However, nano-sizing the substance to obtain a nano-scale product can effectively improve the quality.

[0005] Nano spray drying is achieved by adding vibrating screen technology and high-efficiency electrostatic particle collection technology to the traditional spray drying preparation technology. It is an advanced preparation technology that directly prepares drug solutions into nanoparticles through nano spray drying technology. This method first sprays the drug solution into nano droplets, and dries the nano droplets through hot air flow (carbon dioxide and nitrogen) in the equipment room, and finally collects the nanoparticles through electrode induction at the bottom of the equipment room. When preparing albumin nanoparticles by this method, the particle size of the obtained nanoparticles can be accurately controlled by optimizing the nano spray drying process parameters (including adjusting the size of the nozzle, air flow temperature, albumin solution concentration and flow rate, etc.), and the encapsulation efficiency and bioavailability of nanoparticles for drugs can be significantly improved. This method can achieve albumin encapsulation of hydrophilic / hydrophobic small molecule drugs, biomacromolecule drugs, small-sized nanoparticles and other materials, and the yield of the obtained nanoparticles can reach up to 95%.

[0006] Based on the prevalence of natural and green cosmetics in the current market, people hope to get a kind of natural cosmetics that are harmless to human health but have beauty effects. Therefore, the use of natural ingredients with biological activity in cosmetics is regarded as the next major innovation in the cosmetics industry. Ganoderma lucidum, as a traditional Chinese medicine, has the characteristics of low irritation, mild effect and significant efficacy. Ganoderma lucidum extract can be added to cosmetics as an additive. How to make full use of Ganoderma lucidum extract, there is no relevant report in the prior art. Summary of the invention

[0007] In view of the shortcomings of the prior art, the present invention provides a nano-scale Ganoderma lucidum and a preparation method and application thereof. The nano-scale Ganoderma lucidum has antioxidant, anti-inflammatory and whitening effects, can effectively alleviate skin allergies and inflammation, and better protect the skin.

[0008] In order to achieve the above object, the specific technical solution adopted by the present invention is:

[0009] A method for preparing nano-scale Ganoderma lucidum comprises the following steps:

[0010] (1) soaking Ganoderma lucidum, subjecting it to vacuum microwave, then dissolving it in water, stirring it, filtering it, and obtaining a nano spray drying preparatory solution;

[0011] (2) subjecting the nano-spray drying preliminary solution to nano-spray drying to obtain nano-scale Ganoderma lucidum;

[0012] Among them, the parameters of nano spray drying include: the inlet temperature of the spray drying cylinder is 95-105°C.

[0013] Preferably, the infiltration solvent in step (1) is water, the infiltration temperature is 75-85° C., and the infiltration time is 55-70 min.

[0014] Preferably, the vacuum degree of the vacuum microwave in step (1) is 60-80 KPa, and the power density of the vacuum microwave is 9.6-12.8 W·g -1 , the temperature of the vacuum microwave is 60-70°C, and the time of the vacuum microwave is 170-190s.

[0015] Preferably, in step (1), the liquid-to-solid ratio of Ganoderma lucidum to water is 1 mg:8-12 mL, the stirring temperature is 55-65° C., and the stirring time is 35-45 min.

[0016] Preferably, in step (1), a filter membrane with a pore size of 0.4-0.5 μm is used for filtration.

[0017] Preferably, the parameters of nano spray drying also include: a spray rate of 95%-105%, a gas flow rate of 120-140 L / min, and a spray cap aperture of 3.5-4.5 μm.

[0018] The invention also relates to the nano-scale ganoderma lucidum prepared by the preparation method.

[0019] Preferably, the particle size of the nano-scale Ganoderma lucidum is 300-320nm.

[0020] The present invention also relates to the application of the nano-scale ganoderma lucidum prepared by the preparation method in the preparation of cosmetics.

[0021] Preferably, the cosmetic has the effects of whitening, anti-inflammation, anti-oxidation and improving seborrheic alopecia.

[0022] Since nano-level Ganoderma lucidum has anti-inflammatory and skin-improving effects, and is a natural product with the advantage of fewer side effects on the skin, it can effectively solve problems such as skin allergies and inflammation during the use of cosmetics. At the same time, this substance also has antioxidant function.

[0023] The present invention utilizes a microwave radiation pretreatment extraction method. Mainly, before the water bath immersion, the already soaked material is subjected to microwave radiation to destroy the cell structure of the material, thereby making the material easier to extract in the subsequent process. The specific principle of this technology is as follows: microwave is a high-frequency electromagnetic wave, and its working principle is to utilize the high-frequency oscillation of the electric field and magnetic field in space to induce the polar molecules in the material to produce high-frequency motion, so that the material as a whole produces thermal and non-thermal effects. The thermal effect can cause the water inside the material to heat up and vaporize. The rapid temperature rise causes the structural organization of the material to change, and the material becomes loose: the non-thermal effect is that the polar molecules cause strong polarity oscillations under the action of the alternating electromagnetic field of the microwave, which causes the hydrogen bonds between the cell molecules to relax and the cell membrane structure to be ruptured by electrical breakdown.

[0024] The present invention uses nano spray technology to prepare nano-grade ganoderma lucidum, so as to improve the transdermal absorption ability and solubility of ganoderma lucidum. At the same time, nano-grade ganoderma lucidum can also effectively improve the inhibitory effect on mushroom tyrosinase and mouse melanoma cell (B16) melanin content and mouse melanoma cell tyrosinase, reduce the generation of melanin and its intermediate tyrosinase, and play a whitening effect. Finally, it is further verified by zebrafish test that nano-grade ganoderma lucidum can effectively inhibit the production of melanin. Afterwards, a transdermal absorption test is used to explore the strength of the penetration of nano-grade and non-nano-grade ganoderma lucidum. The results show that the 5-hour penetration amount of nano-grade ganoderma lucidum is 3 times that of non-nano, and the penetration rate of nano-grade ganoderma lucidum is 2 times that of non-nano.

[0025] Tyrosinase (EC 1.14.18.1) is a complex copper-containing oxidoreductase widely found in microorganisms, plants and animals, and the human body. Tyrosinase has a dual catalytic function, which can catalyze the hydroxylation of L-tyrosine to form L-DOPA (single oxidase), and then oxidize L-DOPA to form dopaquinone (double oxidase). Dopaquinone substances are converted into melanin through a series of enzymatic and non-enzymatic reactions. Therefore, tyrosinase is a key enzyme in the formation of melanin. The present invention tests the inhibitory activity of mushroom tyrosinase, and uses kojic acid as a reference substance to detect the inhibitory effects of nano- and non-nano-grade Ganoderma lucidum on it. The results show that the inhibitory effect is increased after Ganoderma lucidum is prepared into nano-grade.

[0026] Hyaluronic acid plays an important role in many developmental and regulatory processes of the human body, such as cell adhesion, organ formation, wound healing, tumorigenesis and angiogenesis. Inhibiting the activity of hyaluronidase can prevent hyaluronic acid from being decomposed and maintain normal physiological functions. The present invention uses dexamethasone as a reference substance to detect the inhibitory effect of nano-scale Ganoderma lucidum and non-nano-scale Ganoderma lucidum on hyaluronidase. The results show that the inhibitory effect is enhanced after nano-scale.

[0027] LPS can induce macrophages to produce a variety of inflammatory cytokines and inflammatory mediators, thereby triggering a series of inflammatory responses in the body. In the LPS-induced RAW 264.7 cell inflammation model, NO is one of the inflammatory mediators. Excessive NO will react with superoxide anions to produce peroxynitrite, thereby causing local tissue damage and promoting the occurrence of inflammation. Therefore, NO production inhibition activity is the simplest and most effective method to evaluate anti-inflammatory potential. The present invention measured the release of nitric oxide in mouse RAW 246.7 cells, and compared nano-scale and non-nano-scale Ganoderma lucidum to find that nano-scale Ganoderma lucidum can effectively reduce the release of NO and produce a good anti-inflammatory effect. Subsequent evaluation of zebrafish anti-inflammatory effects found that nano-scale Ganoderma lucidum can significantly inhibit the aggregation of macrophages to the inflamed area of ​​the zebrafish tail fin, that is, it has potential anti-inflammatory effects.

[0028] The present invention constructs an in vitro and in vitro model of inflammation using RAW 264.7 cells induced by lipopolysaccharide (LPS) to study the inhibitory effect of nano-scale Ganoderma lucidum on inflammation. The results show that nano-scale Ganoderma lucidum can significantly inhibit the release of nitric oxide (NO), regulate the balance of pro-inflammatory / anti-inflammatory factors, and ultimately inhibit the inflammatory cascade reaction by inhibiting the activation of nuclear transcription factor NF-κB.

[0029] Compared with the prior art, the present invention has the following beneficial effects:

[0030] (1) The present invention uses nanotechnology to achieve greater absorption of the active ingredients of the Ganoderma lucidum extract, and the obtained nano-scale Ganoderma lucidum has properties such as viscosity, hydrophilicity, permeability, solubility, etc. that meet the requirements.

[0031] (2) The nano-scale Ganoderma lucidum prepared by the present invention has better anti-inflammatory, antioxidant and whitening effects, and has the effect of improving seborrheic alopecia. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 is a transmission electron microscope image of the nano-sized Ganoderma lucidum in Example 1 and the common Ganoderma lucidum in Comparative Example 1, wherein A is the nano-sized Ganoderma lucidum and B is the common Ganoderma lucidum;

[0033] Figure 2 This is a comparison chart of the transdermal absorption test of the nano-grade Ganoderma lucidum in Example 1 and the common Ganoderma lucidum in Comparative Example 1;

[0034] Figure 3 This is a comparison chart of the mushroom tyrosinase inhibition experiment of the nano-grade Ganoderma lucidum in Example 1 and the common Ganoderma lucidum in Comparative Example 1, wherein A is the nano-grade Ganoderma lucidum, B is the common Ganoderma lucidum, **** indicates that there is an extremely significant statistical difference between the two, P < 0.0001;

[0035] Figure 4 1 is a comparison chart of the hyaluronidase inhibition experiment of the nano-grade Ganoderma lucidum in Example 1 and the common Ganoderma lucidum in Comparative Example 1, wherein A is the nano-grade Ganoderma lucidum and B is the common Ganoderma lucidum, wherein **** indicates that there is an extremely significant statistical difference between the two, P < 0.0001;

[0036] Figure 5 This is a comparison chart of the cytotoxic effects of the nano-grade Ganoderma lucidum in Example 1 and the common Ganoderma lucidum in Comparative Example 1 on RAW 264.7 cells, wherein A is the nano-grade Ganoderma lucidum and B is the common Ganoderma lucidum;

[0037] Figure 61 is a comparison chart of the anti-inflammatory evaluation of the nano-grade Ganoderma lucidum in Example 1 and the common Ganoderma lucidum in Comparative Example 1, wherein A is the nano-grade Ganoderma lucidum, B is the common Ganoderma lucidum, **** indicates that there is an extremely significant statistical difference between the two, P < 0.0001; *** indicates that there is a strong significant statistical difference between the two, P < 0.001; ns indicates that there is no statistical difference;

[0038] Figure 7 1 is a comparison chart of the antioxidant effects of the nano-grade Ganoderma lucidum in Example 1 and the common Ganoderma lucidum in Comparative Example 1, wherein A is the nano-grade Ganoderma lucidum, B is the common Ganoderma lucidum, and **** indicates that there is an extremely significant statistical difference between the two, P < 0.0001;

[0039] Figure 8 This is a comparison chart of the effects of nano-scale Ganoderma lucidum at different concentrations on melanin content and tyrosinase in Example 1, where **** indicates that there is an extremely significant statistical difference between the two, P < 0.0001;

[0040] Fig. 9 This is a graph showing the experimental results of the effect of nano-scale Ganoderma lucidum on the survival rate of zebrafish in Example 1;

[0041] Fig.10 is a graph showing the experimental results of the effect of nano-sized Ganoderma lucidum on the melanin content of zebrafish in Example 1, wherein **** indicates that there is an extremely significant statistical difference between the two, P < 0.0001;

[0042] Fig.11 1 is a graph showing the experimental results of the effect of nano-sized Ganoderma lucidum on the activity of zebrafish tyrosinase in Example 1, wherein **** indicates that there is an extremely significant statistical difference between the two, P < 0.0001;

[0043] Fig.12 is a graph showing the experimental results of evaluating the antioxidant efficacy of nano-sized Ganoderma lucidum on zebrafish in Example 1, wherein **** indicates that there is an extremely significant statistical difference between the two, P < 0.0001;

[0044] Fig.13 This is a graph showing the experimental results of evaluating the anti-inflammatory effect of nano-scale Ganoderma lucidum on zebrafish in Example 1. DETAILED DESCRIPTION

[0045] The present invention will be further described in detail below in conjunction with specific examples. The following examples are not intended to limit the present invention, but are only intended to illustrate the present invention. The experimental methods used in the following examples are generally conventional, unless otherwise specified, and the materials, reagents, etc. used in the following examples are commercially available, unless otherwise specified.

[0046] The invention discloses a nano-level ganoderma lucidum, the main point of which is that the ganoderma lucidum is obtained by treating the ganoderma lucidum fruiting body with the nano-spraying technology.

[0047] The nano spray technology uses natural plant Ganoderma lucidum as raw material to break the wall by microwave radiation to obtain the plant's physiologically active ingredients and special functional ingredients (Ganoderma lucidum polysaccharide), and forms nano-scale powder products through physical and mechanical methods.

[0048] Example 1

[0049] A method for preparing nano-scale Ganoderma lucidum, comprising the following steps:

[0050] (1) 10 mg of Ganoderma lucidum raw material was weighed and placed in a conical flask, and ultrapure water was added at a material-liquid ratio of 1:3, and the mixture was stirred while being added. The mixture was spread and allowed to stand for 15 minutes to allow the solution to fully penetrate into the cell tissue; the fully infiltrated Ganoderma lucidum was placed in a vacuum microwave equipment for rapid heating pretreatment, with a vacuum degree of 70 KPa and a power density of 10.5 W·g -1 , the temperature of the vacuum microwave is 65℃, and the microwave time is 180s. The water that has penetrated into the sample cell tissue is vaporized, and the plant cell tissue is fully destroyed, laying a certain foundation for subsequent extraction. The microwave pretreated common Ganoderma lucidum is dissolved in 100mL of ultrapure water, stirred at 60℃ for 40min, cooled to room temperature, and filtered with a 0.45μm pore size filter membrane to obtain a nano spray drying preparatory solution;

[0051] (2) The nano spray drying preparatory solution was atomized by a nano spray dryer and dried into nano-sized particles in a spray drying cylinder. The process parameters of the nano spray drying were set as follows: the inlet temperature of the spray drying cylinder was 100° C., the spray rate was 100%, the gas flow rate was 130 L / min, and the spray cap aperture was 4 μm.

[0052] The yield of the collected nano-scale Ganoderma lucidum particles was calculated by weighing the mass before and after (nano-scale Ganoderma lucidum particles / Ganoderma lucidum raw material), and the yield was 90%.

[0053] Example 2

[0054] A method for preparing nano-scale Ganoderma lucidum, comprising the following steps:

[0055] (1) Weigh 10 mg of Ganoderma lucidum raw material, put it into a conical flask, add ultrapure water at a material-liquid ratio of 1:5, stir while adding, spread and let stand for 10 minutes, and then put it into a vacuum microwave equipment for rapid heating pretreatment, with a vacuum degree of 60 KPa and a power density of 9.6 W·g -1 , the temperature of the vacuum microwave was 60°C, and the microwave time was 190s. The microwave pretreated common Ganoderma lucidum was dissolved in 95mL of ultrapure water, stirred at 55°C for 45min, cooled to room temperature, and filtered with a filter membrane with a pore size of 0.40μm to obtain a nano-spray drying preparatory solution;

[0056] (2) The nano spray drying preparatory solution was atomized by a nano spray dryer and dried into nano-sized particles in a spray drying cylinder. The process parameters of the nano spray drying were set as follows: the inlet temperature of the spray drying cylinder was 95° C., the spray rate was 95%, the gas flow rate was 120 L / min, and the spray cap aperture was 3.5 μm.

[0057] The yield of the collected nano-scale Ganoderma lucidum particles was calculated by weighing the mass before and after, and the yield was 89%.

[0058] Example 3

[0059] A method for preparing nano-scale Ganoderma lucidum, comprising the following steps:

[0060] (1) Weigh 10 mg of Ganoderma lucidum raw material, put it into a conical flask, add ultrapure water at a material-liquid ratio of 1:2, stir while adding, lay it and let it stand for 20 minutes, and then put it into a vacuum microwave equipment for rapid heating pretreatment, with a vacuum degree of 80 KPa and a power density of 12.8 W·g -1 , the temperature of the vacuum microwave was 70°C, and the microwave time was 170s. The microwave pretreated common Ganoderma lucidum was dissolved in 105mL of ultrapure water, stirred at 65°C for 35min, cooled to room temperature, and filtered with a 0.50μm pore size filter membrane to obtain a nano spray drying preparatory solution;

[0061] (2) The nano spray drying preliminary solution is atomized by a nano spray dryer and dried into nano-sized particles in a spray drying cylinder; the process parameters of the nano spray drying are set as follows: the inlet temperature of the spray drying cylinder is 105° C., the spray rate is 105%, the gas flow rate is 140 L / min, and the spray cap aperture is 4.5 μm.

[0062] The yield of the collected nano-scale Ganoderma lucidum particles was calculated by weighing the mass before and after, and the yield was 87%.

[0063] Comparative Example 1

[0064] A common ganoderma lucidum granule, the preparation method is as follows:

[0065] Weigh 10 mg of Ganoderma lucidum raw material, put it into a conical flask, add ultrapure water at a material-liquid ratio of 1:3, stir while adding, spread and let stand for 15 minutes; put the fully soaked Ganoderma lucidum into a vacuum microwave equipment for rapid heating pretreatment, the vacuum degree is 70Kpa, the power density is 10.5W·g -1 The temperature of the vacuum microwave was 65°C and the microwave time was 180s. The microwave pretreated common Ganoderma lucidum was dissolved in 100 mL of ultrapure water, stirred at 60°C for 40 minutes, cooled to room temperature, filtered with a 0.45 μm pore size filter membrane, and dried to obtain common Ganoderma lucidum particles.

[0066] Comparative Examples 2-3

[0067] The difference between Comparative Examples 2-3 and Example 1 is that the spraying rates in step (2) are different, namely 80% and 120%, respectively. The yield of the collected nano-scale Ganoderma lucidum particles was calculated by weighing the mass before and after, and the results are shown in Table 1.

[0068] Table 1 Comparative Example 2-3 Nano-scale Ganoderma Lucidum Particle Yield

[0069] Group Yield Comparative Example 2 77% Comparative Example 3 75%

[0070] Comparative Examples 4-6

[0071] The difference between Comparative Examples 4-6 and Example 1 is that the inlet temperature of the spray drying drum in step (2) is different, namely 50° C., 70° C. and 120° C. The yield of the collected nano-scale Ganoderma lucidum particles was calculated by weighing the mass before and after, and the results are shown in Table 2.

[0072] Table 2 Comparative Examples 4-6 Nano-scale Ganoderma Lucidum Particle Yield

[0073] Group Yield Comparative Example 4 (50°C) 54% Comparative Example 5 (70°C) 71% Comparative Example 6 (120°C) 82%

[0074] Comparative Examples 7-9

[0075] The difference between Comparative Examples 7-9 and Example 1 is that the microwave vacuum degree in step (1) is different, namely 50 KPa, 90 KPa, and 100 KPa. The yield of the collected nano-scale Ganoderma lucidum particles was calculated by weighing the mass before and after, and the results are shown in Table 3.

[0076] Table 3 Comparative Examples 6-8 Nano-scale Ganoderma Lucidum Particle Yield

[0077] Group Yield Comparative Example 7 (50Kpa) 67% Comparative Example 8 (90Kpa) 71% Comparative Example 9 (100Kpa) 74%

[0078] Comparative Examples 10-11

[0079] The difference between Comparative Examples 10-11 and Example 1 is that the solid-liquid ratio in the water extraction process of step (1) is different. The solid-liquid ratios of Comparative Examples 10-11 are 1 mg:5 mL and 1 mg:25 mL, respectively. The mass of the nano-scale Ganoderma lucidum particles collected was weighed before and after to calculate the yield. The results are shown in Table 4.

[0080] Table 4 Yield of Nano-scale Ganoderma Lucidum Particles of Comparative Examples 10-11

[0081] Group Yield Comparative Example 10 71% Comparative Example 11 85%

[0082] Effect test

[0083] 1. Transmission Electron Microscopy

[0084] The nano-sized Ganoderma lucidum in Example 1 and the common Ganoderma lucidum in Comparative Example 1 were tested by transmission electron microscopy (TEM). The results are as follows: Figure 1 shown.

[0085] Through the scanning comparison of electron microscope, we can get the nano-scale Ganoderma lucidum ( Figure 1 B) is better than ordinary Ganoderma lucidum ( Figure 1 The particle size of A) in the above-mentioned is smaller, which is 300-320nm, which is beneficial to increase its penetration and improve the solubility of the substance for further development and utilization.

[0086] 2. Transdermal absorption test

[0087] The transdermal absorption test used a modified Franz diffusion apparatus, with pig skin fixed between the drug administration pool and the receiving pool. The effective permeation area of ​​the diffusion pool was 2.54 cm 2 , the stratum corneum faces the supply chamber, and the dermis faces the receiving chamber. Weigh 1 mL of the sample agent, place it in the dosing pool, and apply it evenly on the ex vivo pig skin of the same size. Fix the upper and lower chambers, keep the temperature at (37±0.5)℃, set the diffusion cell speed to 200r / min and stir continuously, and take 3.0 mL of receiving solution after 1.0, 6.0, 20.0, and 39.0h, respectively, and replenish the same temperature and equal volume of receiving solution at the same time. Centrifuge the receiving solution, take the supernatant and filter it with a microporous filter membrane, measure the absorbance of the filtrate according to the given chromatographic conditions, and calculate the cumulative permeation per unit area Q. The calculation formula is as follows.

[0088]

[0089] Among them, c n is the drug concentration measured at the nth sampling point; V is the volume of the receiving pool; S is the effective diffusion area.

[0090] Cumulative permeability per unit area: K = [Q / m] × 100%, where m is the amount of 1 mL of solution sample.

[0091] Experimental process: pig skin was used as in vitro transdermal absorption skin, and the diffusion cell method was used to perform a transdermal test on the in vitro transdermal absorption skin. When used, 2 parts of the in vitro transdermal absorption skin were fixed on the Franz diffusion cell respectively, and physiological saline was used as the receiving liquid at a temperature of 37°C. Solutions were prepared according to the ratio of 1 part of Example 1 to 30 parts of distilled water and 1 part of Comparative Example 1 to 30 parts of distilled water, and added to the corresponding supply chamber for measurement, and the cumulative drug permeation at each time point was calculated. The results are shown in Table 5.

[0092] Table 5 Transdermal absorption test

[0093] Group 1h 3h 5h Example 1 <![CDATA[1.3721mg / cm 2 ]]> <![CDATA[1.7986mg / cm 2 ]]> <![CDATA[2.0872mg / cm 2 ]]> Comparative Example 1 <![CDATA[0.4581mg / cm 2 ]]> <![CDATA[0.6273mg / cm 2 ]]> <![CDATA[0.7872mg / cm 2 ]]>

[0094] According to Table 5 above, the 5-hour permeability of nano-grade Ganoderma lucidum is about 3 times that of ordinary Ganoderma lucidum. The 5-hour permeability of nano-grade Ganoderma lucidum calculated by the above unit area cumulative permeability formula is 57.98%; the permeability of ordinary Ganoderma lucidum is 32.80%, that is, the 5-hour permeability of nano-grade Ganoderma lucidum is about 2 times that of ordinary Ganoderma lucidum. Figure 2 shown.

[0095] 3. Mushroom tyrosinase inhibition test

[0096] In vitro tyrosinase activity evaluation: The mother solutions prepared by mixing Ganoderma lucidum obtained in Example 1 and Comparative Example 1 with water at a ratio of 1:30 were used as sample solutions, and 30 parts of water were added to 1 part of kojic acid to prepare a positive control, and in vitro tyrosinase inhibitory activity evaluation was performed.

[0097] The specific process of the in vitro tyrosinase inhibition activity experiment is as follows:

[0098] The in vitro tyrosinase experiment was divided into a blank control group, a sample group and a positive control group, and 3 parallel wells were set for each group. The blank control group (equal volume of disodium hydrogen phosphate-citrate buffer), the sample group added 100 μL of culture medium containing different concentrations of sample solution of Example 1 and Comparative Example 1, and the positive control group added 100 μL of kojic acid dissolved in PBS and at a concentration of 1.0 μg / mL. L-Tyrosine was used as a monophenol substrate, 40 μL L-Tyrosine solution (0.5 mM) was taken, 40 μL sample solution and 80 μL phosphate buffer solution (0.05 M, pH 6.8) were added, and 40 μL tyrosinase solution (250 U / mL) was added to start the reaction after being incubated at 37 ° C for 10 min, and the absorbance values ​​of 0 min and 30 min were measured respectively at a wavelength of 475 nm in an ELISA reader (Enspire Xenon Light Module, 200 Perkin-Elmer, Beaconsfield, UK). The tyrosinase inhibition rate (including the monophenolase inhibition rate of tyrosinase and the diphenolase inhibition rate of tyrosinase) was calculated according to the following formula.

[0099] Tyrosinase inhibition rate (%) = [1-(△A1-△A2) / (△A3-△A4)] × 100%

[0100] Wherein: A1 is the absorbance of the system of substrate, sample solution, tyrosinase and PBS; A2 is the absorbance of the system of sample solution, tyrosinase and PBS; A3 is the absorbance of the system of substrate, tyrosinase and PBS; A4 is the absorbance of the system of tyrosinase and PBS.

[0101] By Figure 3As shown, compared with the control group (kojic acid), nano-scale Ganoderma lucidum has a certain inhibitory effect, which is dose-dependent and has statistical significance (P<0.0001). The cell proliferation rate treated with 0.5μg / mL, 0.8μg / mL, and 1.0μg / mL nano-scale Ganoderma lucidum is significantly increased, which is (49.28±0.27)%, (60.08±0.94)%, and (76.56±0.59)%, respectively, which is 14.23%, 16.74%, and 14.22% higher than that of ordinary Ganoderma lucidum, indicating that nano-scale Ganoderma lucidum can effectively achieve its whitening effect.

[0102] 4. Hyaluronidase Activity Inhibition Experiment

[0103] The Elson-Morgan modified method was used for determination. 50 μL of hyaluronidase solution (7900U / mL) was added to 5 mL centrifuge tubes in sequence, mixed by shaking, and placed in a water bath. After 20 minutes of constant temperature at 37°C, 250 μL of substrate (sodium hyaluronate) solution was added to each tube in sequence, mixed by shaking, and placed in a water bath. After 40 minutes of constant temperature at 37°C, 50 μL of 0.4 mol / L sodium hydroxide solution and 100 μL of 0.2 mol / L sodium borate solution were added, mixed by shaking, and placed in a boiling water bath for 3 minutes. After taking out, cool to room temperature, add 1.5 mL of pDMAB (pDMAB solution is prepared by adding 4 g of p-dimethylaminobenzaldehyde to 50 mL of 10 mol / L HCl, and then adding 350 mL of glacial acetic acid solution), mix by shaking, and place in a water bath. After 20 minutes of constant temperature at 37°C, take out and cool to room temperature. Take 200 μL from each centrifuge tube, place it in an ELISA plate, and scan the wavelength. Test the sample absorbance at a wavelength of 530 nm, and measure each sample in parallel 3 times. The Ganoderma lucidum in Comparative Example 1, the nano-grade Ganoderma lucidum in Example 1, and the positive control dexamethasone are respectively prepared into 0.8 mg / mL mother solutions for detection, and the inhibition rate calculation formula is as follows.

[0104] Inhibition rate (%) = [(T0-T) / T0] × 100%

[0105] Wherein, T0 is the absorbance of the sample solvent in the reaction between the enzyme and the substrate, and T is the absorbance of the sample in the reaction between the enzyme and the substrate.

[0106] By Figure 4As shown, compared with ordinary Ganoderma lucidum, the inhibitory effect of Ganoderma lucidum on hyaluronidase is enhanced after nano-scale Ganoderma lucidum is nano-scaled, and the growth rates are 1.73%, 2.92%, and 3.71%, respectively, and are dose-dependent, with statistical differences (P < 0.0001). As the concentration of nano-scale Ganoderma lucidum increases, its inhibitory effect on hyaluronidase activity is enhanced and dose-dependent. Studies have shown that the nano-scale Ganoderma lucidum shows that the present invention has a strong ability to inhibit tyrosinase activity and can effectively improve skin aging problems such as skin pigmentation caused by ultraviolet rays.

[0107] 5. Using lipopolysaccharide to induce RAW246.7 cells to establish an inflammatory model to evaluate the anti-inflammatory effect of nano-sized Ganoderma lucidum

[0108] The experimental raw materials and purchasing manufacturer information involved in this experiment are shown in Table 6.

[0109] Table 6 Experimental raw material information

[0110]

[0111] Cell culture:

[0112] RAW246.7 cells were cultured in DMEM culture medium (containing 10% FBS) in a 37°C, 5% CO2 incubator. The culture medium was replaced after 36 hours. The cells were gently blown off with DEME culture medium containing 10% FBS, the cell suspension was collected, centrifuged (1000r / min, 5min), the supernatant was discarded, and 1mL of DEME cell culture medium containing 10% FBS was added to resuspend the cells and inoculated into a new culture dish at a volume ratio of 1:3 for cell culture.

[0113] (1) Toxicity of nano-sized Ganoderma lucidum to RAW264.7 cells:

[0114] The MTT method was used to detect cell viability to evaluate the toxicity of Ganoderma lucidum extract on RAW264.7 cells. 4 The cells were inoculated into a 96-well plate at a density of 100 cells, cultured overnight, and the next day, culture solution containing different concentrations of the common Ganoderma lucidum in Comparative Example 1 and the nano-Ganoderma lucidum in Example 1 (final concentrations of 0, 0.25, 0.5, 0.75, 1.00 mg / mL) was added and cultured for 48 hours. After full action, the culture medium in the well plate was carefully sucked out, 100 μL PBS and 10 μL MTT solution were added to each well, and after 4 hours of culture, 100 μL DMSO solution was added to each well and incubated overnight. The absorbance value (OD value) at 570 nm of the well plate was tested with an ELISA instrument. Calculate the cell proliferation rate (%) = average OD value of the drug group / average OD value of the control group × 100%.

[0115] The results are as follows Figure 5 As shown. Figure 5 The results showed that as the concentration of Ganoderma lucidum and nano-Ganoderma lucidum increased, the growth of RAW264.7 could be inhibited. When the concentration was 0.25 and 0.5 mg / mL, the survival rate of RAW264.7 cells was above 95%, that is, 0.25 and 0.5 mg / mL were selected as the subsequent experimental concentrations.

[0116] (2) Construction of RAW 264.7 cell inflammatory cell model and evaluation of anti-inflammatory activity of nano-scale Ganoderma lucidum

[0117] The Griess method was used to determine the amount of nitric oxide produced by RAW264.7 cells. Griess reagent was prepared by mixing equal volumes of Griess A solution (0.1% naphthylethylenediamine hydrochloride) and Griess B solution (20% sulfonamide dissolved in phosphoric acid). A standard curve was established using 0 to 100 μM NaNO2 solution as the standard. After the culture was completed, 100 μL of supernatant was taken from the well plate, and 100 μL of Griess reagent was added and incubated at room temperature for 30 minutes. The light absorbance (OD value) of the well plate at 540 nm was measured using an ELISA reader. Logarithmically growing RAW264.7 cells were taken at a rate of 1×10 5 The number of cells / well was inoculated into a 24-well plate, and then placed in a 37°C, 5% CO2 incubator for 24 hours. A blank group, a model group, and a drug-treated group were set up. The drug-treated group was added with 500 μL / well of 0.25 and 0.5 mg / mL of Ganoderma lucidum in Comparative Example 1, the nano-grade Ganoderma lucidum in Example 1, and 0.5 mg / mL of dexamethasone (positive control), followed by LPS solution. The model group was added with 500 μL / well of culture solution, followed by LPS solution. The blank group was added with the same volume of culture solution. The supernatant was collected after 24 hours of continuous culture under the same conditions. The OD value was determined according to the instructions of the nitric oxide synthase kit. The results are shown in Figure 6 shown.

[0118] The results showed that the release of NO decreased with the increase of the extract concentration, and the release of NO was the lowest at 0.5 mg / mL, with the values ​​of ordinary Ganoderma lucidum, nano-Ganoderma lucidum and dexamethasone being 5.78, 3.70 and 5.56 respectively. Compared with ordinary Ganoderma lucidum, at a concentration of 0.5 mg / mL, the NO release decreased by 2.08 μmol / L after Ganoderma lucidum was converted into nano-Ganoderma lucidum. Since the nitric oxide content was negatively correlated with the anti-inflammatory activity, nano-Ganoderma lucidum had potential anti-inflammatory effects.

[0119] 6. Construction of H2O2-induced oxidative damage model in RAW264.7 cells

[0120] RAW264.7 cells were plated in a 96-well plate. RAW264.7 cells were divided into a blank group, a damaged group and a sample group, with 3 parallel wells in each group. The blank group was given normal culture medium, and the damaged group was added with H2O2 (800 μmol / L) at the optimal damaging concentration; the sample group was first pretreated with different concentrations of nano-grade Ganoderma lucidum in Example 1 and ordinary Ganoderma lucidum in Comparative Example 1 for 24 hours, and then H2O2 at the optimal damaging concentration was added for oxidative damage for 2 hours. After that, the culture medium was replaced and incubated for another 24 hours. Finally, the cell proliferation rate was detected with CCK-8, and the effects of different H2O2 concentrations on the cell proliferation rate were calculated. The calculation formula is as follows.

[0121] Cell proliferation rate (%) = (A1-A2) / (A3-A2) × 100%

[0122] Wherein: A1 is the absorbance value containing cells, CCK-8, sample and H2O2; A2 is the absorbance value containing CCK-8 but not containing cells, sample and H2O2; A3 is the absorbance value containing cells, CCK-8 but not containing sample and H2O2.

[0123] By Figure 7 As shown, compared with the blank group, the cell proliferation rate in the H2O2 model group was significantly reduced, with a statistical difference (P < 0.0001), indicating that the model was successfully established. Compared with the H2O2 model group, the cell proliferation rate treated with 0.25 mg / mL and 0.5 μg / mL nano-level Ganoderma lucidum was significantly increased, which was (79.62 ± 1.78)% and (86.14 ± 2.18)%, respectively, which was 28.32% (P < 0.001) and 34.84% (P < 0.0001) respectively compared with the model group, with a statistical difference, indicating that nano-level Ganoderma lucidum has a good ability to protect against oxidative damage.

[0124] 7. Effect Assay on B16 Mouse Melanoma Cells

[0125] The experimental raw materials and purchasing manufacturer information involved in this experiment are shown in Table 7.

[0126] Table 7 Experimental raw material information

[0127]

[0128] The tyrosinase activity in B16 mouse melanoma cells was measured by L-DOPA oxidation method. B16 mouse melanoma cells were plated in 96-well plates according to the above method. B16 mouse melanoma cells were divided into a blank control group, a sample group and a positive control group, with 3 parallel wells in each group. 100 μL of normal culture medium was added to the blank control group, 100 μL of culture medium containing samples of nano-scale Ganoderma lucidum of different concentrations in Example 1 was added to the sample group, and 100 μL of arbutin at a concentration of 0.5 mg / mL was added to the positive control group. The cells were collected after incubation for 24 hours. The 1.0×10 5 Adjust the cell density with 10 cells / 1mL, place them in EP tubes, discard the supernatant after centrifugation, add 1mL of 0.5% sodium deoxycholate solution, and vortex thoroughly to mix. Then freeze at 0℃ for 20min and place at 37℃ for 30min. Then aspirate the cell lysate into a 96-well plate, add 10μL of 0.5% L-DOPA solution to each well, incubate at 37℃ for 30min, and measure the absorbance of each well at 475nm with an enzyme reader. Calculate the tyrosinase activity in B16 melanoma cells according to the following formula.

[0129] Tyrosinase activity (%) = (OD 样品 / OD 空白 )×100%

[0130] By Figure 8 As shown, compared with the blank group, the tyrosinase inhibition rates were 60.20% and 81.06%, respectively, with statistical differences (P<0.0001). As the concentration of nano-level Ganoderma lucidum increased, its inhibitory effect on the activity of tyrosinase in B16 melanoma cells increased and was dose-dependent. The trend of melanin content change was consistent with the trend of tyrosinase activity. Compared with the blank group, it was reduced by 28.64% and 45.64%, respectively, with statistical differences (P<0.0001). As the concentration of nano-level Ganoderma lucidum increased, its inhibitory effect on the synthesis of melanin in B16 melanoma cells increased and was dose-dependent. Therefore, the whitening mechanism of nano-level Ganoderma lucidum is to reduce the content of melanin production and reduce skin pigmentation by inhibiting tyrosinase activity.

[0131] 8. Study on the whitening effect of nano-sized Ganoderma lucidum based on zebrafish model

[0132] Zebrafish culture: Wild-type zebrafish were raised in an environment with a water temperature of 28.5℃ and pH 8.0. Ten groups of zebrafish were placed in a breeding tank with a partition at a breeding ratio of 1:2 between male and female. The males and females were separated and treated in the dark for 12 hours before the light treatment was restored. The partition was removed to allow the zebrafish to mate and obtain eggs. Healthy zebrafish with a fertilization rate of ≥80% were selected for the experiment.

[0133] (1) Effect of nano-sized Ganoderma lucidum with whitening effect on the survival rate of zebrafish

[0134] Zebrafish eggs are highly sensitive. Toxicity verification was performed before the activity experiment. Healthy zebrafish eggs were collected in a 96-well plate and plated at a density of 1 per well. 180 μL of zebrafish culture water containing different concentrations of nano-sized Ganoderma lucidum (25, 50, 75 and 100 μg / mL) with whitening effect in Example 1 was added to each well. Embryonic death and teratogenicity were observed every 24 hours. The observation was continued for 5 days to observe the effect of 100 μg / mL of nano-sized Ganoderma lucidum (Example 1) with whitening effect on zebrafish development. The results are as follows: Fig. 9 shown.

[0135] from Fig. 9 It can be seen that at a concentration of 100 μg / mL, all zebrafish treated with the nano-sized Ganoderma lucidum with whitening efficacy (Example 1) survived and were in normal physiological state. Based on this, the whitening efficacy of the nano-sized Ganoderma lucidum with whitening efficacy will be studied.

[0136] (2) Effects of nano-sized Ganoderma lucidum with whitening effect on melanin content and tyrosinase activity in zebrafish

[0137] The zebrafish eggs produced are transparent. As the fertilized eggs develop, melanin is gradually produced on the surface and inside the zebrafish eggs. Eventually, the eggs develop into fish. The black production on the surface of the zebrafish can be directly observed, reflecting the effect of the sample on the synthesis of melanin in zebrafish, and then the whitening effect can be evaluated. Glutathione (GSH) is a short segment with antioxidant and whitening effects. It is often used in functional foods or cosmetics and can be used as a positive control for whitening active brain.

[0138] Healthy zebrafish eggs were collected 24 hours after fertilization, and were plated in a 12-well plate at a density of 20 per well. 2 mL of zebrafish culture water (100 μg / mL) containing nano-scale Ganoderma lucidum (Example 1) with whitening effect was added respectively, and a blank group (2 mL culture water) and a positive control group (culture water containing GSH, 100 μg / mL) were set respectively. After constant temperature treatment at 28.5°C for 48 hours, the zebrafish were observed under a stereoscope (Nikon SMZ460, Nikon corporation, Japan) for morphology and melanin distribution and a side view was taken. The remaining zebrafish were collected, washed with distilled water, and then frozen (-80°C) and killed. 200 μL of Western and IP cell lysate (containing 1% (volume fraction) 1mM PMSF) after ice bath was added and the fish body was broken by repeated freezing and thawing for 3 times and centrifuged at 4000r / min for 10 minutes to obtain a supernatant and a precipitate.

[0139] The precipitate was used to determine the melanin content. 250 μL NaOH solution (1M, 10% DMSO) was added to the precipitate, and the precipitate was placed in a water bath at 85°C for 2 h. 100 μL was added to a 96-well plate and the absorbance was determined at 405 nm. Each sample was normalized with a BCA kit (Biyuntian). The relative melanin content was calculated according to the following formula.

[0140] Relative melanin content / % = (A t / A0)×100%

[0141] Where: A t is the absorbance value of the nano-Ganoderma lucidum treated group or the positive control (GSH) group with whitening effect; A0 is the absorbance value of the blank group.

[0142] from Fig.10 As shown in A, compared with the blank group, at 100 μg / mL, the melanin in the eye area of ​​the zebrafish treated with nano-level Ganoderma lucidum with whitening effect was slightly lighter in the side view, and the fish body was more transparent than the blank group.

[0143] The test results of relative melanin content are as follows Fig.10 As shown in B, from Fig.10 As shown in Figure B, the melanin content of zebrafish treated with nano-level Ganoderma lucidum, which has whitening effect, was significantly lower than that of the blank group (p<0.0001). Under the treatment of nano-level Ganoderma lucidum at a concentration of 100 μg / mL, the melanin content in zebrafish was reduced by 38.63% compared with the blank group. This shows that nano-level Ganoderma lucidum has good melanin inhibition ability.

[0144] The supernatant was used to determine the tyrosinase activity. 20 μL of the supernatant and 180 μL of L-DOPA (1 mg / mL) were mixed in a 96-well plate and incubated at 37°C for 2 h in the dark. The absorbance was measured at 75 nm, and the relative tyrosinase activity was calculated according to the following formula.

[0145] Relative tyrosinase activity / % = (A t ' / A0')×100%

[0146] Where: A t ' is the absorbance value of the nano-sized Ganoderma lucidum treated group with whitening effect or the positive control (GSH) group; A0' is the absorbance value of the blank group.

[0147] The relative tyrosinase activity test results are as follows Fig.11As shown, compared with the blank group, the nano-scale Ganoderma lucidum with whitening effect (Example 1) can significantly reduce the tyrosinase activity in zebrafish (p<0.0001). Under the treatment of nano-scale Ganoderma lucidum with a concentration of 100 μg / mL, the tyrosinase activity of zebrafish was reduced by 28.35% compared with the blank group. It shows that the nano-scale Ganoderma lucidum with whitening effect has good tyrosinase inhibition ability.

[0148] The above results show that nano-scale Ganoderma lucidum with whitening effect has good tyrosinase inhibitory activity in the zebrafish model, and can reduce the amount of melanin production by inhibiting enzyme activity, thereby achieving a whitening effect.

[0149] 9. Antioxidant test

[0150] Under a stereomicroscope, 9hpf wild-type zebrafish embryos with normal development were randomly selected and placed in a 6-well cell culture, 20 per well, and the tested zebrafish were divided into three groups, namely, a blank group, a model group, a positive control group, and a nano-level Ganoderma lucidum group. The normal group did not ingest menadione, and the other groups ingested an equal amount of menadione (menadione was ingested into the zebrafish by dissolving it in the fish farming water). The positive control group ingested reduced glutathione after ingesting menadione, and the nano-level Ganoderma lucidum group ingested nano-level Ganoderma lucidum. According to the safety evaluation results, the concentration of the tested sample was set to 0.15%.

[0151] The culture water in the 6-well plate was aspirated, 5.0 mL of buffer water was added to each well of the blank group, 4500.0 μL of buffer water was added to each well of the model control group, and 4500.0 μL of sample solution was added to each well of the test sample group. After pretreatment for 1 h, 500.0 μL of menadione was added to each well of the model group and the test sample group to construct an oxidative stress model, and the plates were incubated in a constant temperature incubator at 28 °C for 24 h.

[0152] After incubation for 24 h, the embryos in each well were transferred to a new six-well plate, each well was washed three times with culture water, and finally 5.0 ml of culture water was added and cultured in a 37°C constant temperature incubator until 3 dpf.

[0153] After 3 dpf, the egg membranes in each well were aspirated, and 5.0 mL (20 μg / mL) of fluorescent probe (DCHF-DA) was added to each well to detect ROS content, and the embryos were cultured in the dark for 50 min. The embryos were then washed three times with culture water, anesthetized with tricaine, observed and recorded under a fluorescence microscope, and the fluorescence intensity was analyzed using Image J.

[0154] from Fig.12 As shown in A, compared with the blank group, the fluorescence brightness of the nano-Ganoderma lucidum in the fluorescence image of zebrafish treated with nano-Ganoderma lucidum is significantly lower than that of the model group, which means that it has potential antioxidant effect.

[0155] The test results of the relative level of ROS are as follows Fig.12 As shown in Figure B, compared with the model group, the ROS content of zebrafish treated with nano-Ganoderma lucidum was significantly reduced (p<0.0001), indicating that nano-Ganoderma lucidum exhibits good antioxidant capacity.

[0156] 10. Horsefish Tail Transection Inflammation Model Experiment

[0157] 3dpf zebrafish larvae in good condition were selected, anesthetized with 0.03% tricaine solution, placed on a glass slide, and the tail fin of the larvae was cut off with a scalpel. After resuscitation in culture water at 28.5°C, they were randomly assigned to groups of 15 fish in each group, and each group was given a nano-grade Ganoderma lucidum solution (100μg / mL). The zebrafish in the normal control group did not undergo tail fin transection. 4 hours after administration, the larvae were placed on an agar plate, and the distribution and number of neutrophils in the zebrafish tail were observed using a stereo fluorescence microscope. The neutrophils in the zebrafish tail were photographed and counted, and statistical analysis was performed. The results are as follows: Fig.13 shown.

[0158] from Fig.13 As shown in A, compared with the model group, the nano-sized Ganoderma lucidum tail had fewer neutrophils, and Fig.13 It can be seen from B that nano-level Ganoderma lucidum can effectively reduce neutrophils, that is, nano-level Ganoderma lucidum has potential anti-inflammatory effects.

[0159] 11.5 α-Reductase Inhibition Assay

[0160] The 5α-reductase inhibition test was conducted using common Ganoderma lucidum (Comparative Example 1) and nano-sized Ganoderma lucidum (Example 1) as the test group. Experimental method: a control group solution and a test group solution were prepared respectively and incubated.

[0161] Control group solution: enzyme reaction system, incubate the enzyme reaction system at 37°C for 30 minutes.

[0162] The formula of the enzyme reaction system is as follows: 5 mL of deionized water, 2 μL of 1 mmol / L testosterone, 600 μL of 10 mg / mL rat steroid 5α-reductase solution, and 200 μL of 1 mmol / L NADPH solution.

[0163] Detection group solution: The samples to be tested (nano-grade Ganoderma lucidum and common Ganoderma lucidum) were dissolved in 50% ethanol to prepare a detection group solution with a concentration of 1%. 0.5 mL of the detection group solution was placed in the enzyme reaction system and incubated at 37° C. for 30 min.

[0164] Detection method: Use UV-visible spectrophotometer to detect the decrease in absorbance of the control group solution and the test group solution before and after incubation at a wavelength of 340nm. The decrease in absorbance of the control group solution is recorded as ΔA1, and the decrease in absorbance of the test group solution is recorded as ΔA n (ΔA 纳米级灵芝 , ΔA 普通灵芝 ), and calculated the enzyme activity inhibition rate, the calculation formula is as follows.

[0165] Enzyme activity inhibitor / % = (ΔA1-ΔA n ) / ΔA1×100%

[0166] Where: A1 is the decrease in absorbance of the control solution, ΔA n =ΔA 纳米级灵芝 , ΔA 普通灵芝 , which are the absorbance decrease values ​​of the test group solutions prepared with nano-grade Ganoderma lucidum and ordinary Ganoderma lucidum, respectively.

[0167] Note: 5α-reductase can convert testosterone into dihydrotestosterone under the action of NADPH. NADPH will become oxidized NADP after participating in the reaction. + DADP has characteristic absorption at 340nm. + There is no characteristic absorption at 340nm. Therefore, by comparing the absorbance change values ​​of the control group solution and the test group solution, the activity inhibition of 5α-reductase can be determined. The test results are shown in Table 8.

[0168] Table 8 5α-reductase inhibition test results of nano-sized Ganoderma lucidum and common Ganoderma lucidum

[0169] Detection object Enzyme activity inhibition rate (%) Comparative Example 1 (Ordinary Ganoderma Lucidum) 19.7 Example 1 (Nano-grade Ganoderma lucidum) 25.3

[0170] According to the test results in Table 8 above, both nano-grade Ganoderma and common Ganoderma have significant inhibitory effects on 5α-reductase; the inhibitory effect of nano-grade Ganoderma on 5α-reductase is better than that of common Ganoderma, that is, nano-grade Ganoderma can be used in shampoo to improve the problem of seborrheic alopecia.

[0171] The above detailed description is a specific description of one feasible embodiment of the present invention. The embodiment is not intended to limit the patent scope of the present invention. Any equivalent implementation or modification that does not deviate from the present invention should be included in the scope of the technical solution of the present invention.

Claims

1. A method for preparing nano-scale Ganoderma lucidum, characterized in that: The following steps are involved: (1) soaking the Ganoderma lucidum powder, subjecting it to vacuum microwave, then extracting it with water, filtering it, and obtaining a nano spray drying preparatory solution; (2) subjecting the nano-spray drying preliminary solution to nano-spray drying to obtain nano-scale Ganoderma lucidum; Among them, the parameters of nano spray drying include: the inlet temperature of the spray drying cylinder is 95-105°C.

2. The preparation method according to claim 1, characterized in that: The infiltration solvent in step (1) is water, the infiltration temperature is 75-85° C., and the infiltration time is 55-70 min.

3. The preparation method according to claim 1, characterized in that: The vacuum degree of the vacuum microwave in step (1) is 60-80 KPa, and the power density of the vacuum microwave is 9.6-12.8 W·g -1 , the temperature of the vacuum microwave is 60-70°C, and the time of the vacuum microwave is 170-190s.

4. The preparation method according to claim 1, characterized in that: The solid-liquid ratio of the ganoderma lucidum powder to water in step (1) is 1 mg: 8-12 mL. Stirring is performed during the water extraction process. The stirring temperature is 55-65° C. and the stirring time is 35-45 min.

5. The preparation method according to claim 1, characterized in that: In step (1), a filter membrane with a pore size of 0.4-0.5 μm is used for filtration.

6. The preparation method according to claim 1, characterized in that: The parameters of nano spray drying also include: spray rate of 95%-105%, gas flow rate of 120-140L / min, and spray cap aperture of 3.5-4.5μm.

7. A nano-scale Ganoderma lucidum obtained by the preparation method according to any one of claims 1 to 6.

8. The nano-scale Ganoderma lucidum according to claim 7, characterized in that: The particle size of the nano-level Ganoderma lucidum is 300-320nm.

9. Use of the nano-scale Ganoderma lucidum prepared by the preparation method according to any one of claims 1 to 6 in the preparation of cosmetics.

10. The use according to claim 9, characterized in that: The cosmetic has the functions of whitening, anti-inflammation, anti-oxidation and improving seborrheic alopecia.

Citation Information

Patent Citations

  • Nano ganoderma medicine and its preparing process

    CN1365690A

  • Nanometer ganoderma amboinense capsule

    CN202173612U

  • Nanometer capsule contg deer antler and glossy ganoderma

    CN2801160Y